StockData

Silicon Laboratories vs Synaptics

SLAB and SYNA side by side, both in electronic components and accessories. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.

How SLAB and SYNA compare

Silicon Laboratories is the larger company, worth 1.6 times as much as Synaptics ($7.4B against $4.6B).

Silicon Laboratories grew revenue faster over the last twelve months (21.3% versus 8.1% for Synaptics).

Silicon Laboratories keeps more of each dollar of sales as profit, with a net margin of −2.3% compared with −40.7% at Synaptics.

Silicon Laboratories scores higher on the StockData Score (7 against 3 for Synaptics), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.

Key numbers

A dot marks the better figure where higher or lower is clearly better.

MetricSLABSYNA
Size and price
Market cap$7.4B$4.6B
Share price$221.43$118.14
Change, 1 year74.4%74.8%
Change, 5 years7.9%−57.6%
Beta (5Y)1.361.98
Employees1,9301,700
StockData Score
Total score7 (better)3
Valuation score00
Growth score2 (better)1
Performance score00
Health score5 (better)2
Dividend score00
Valuation
P/S8.2×3.9× (better)
P/B6.6×5.0× (better)
P/FCF1041×71.3× (better)
FCF yield0.10%1.4% (better)
Fair value$128.32$92.62
Margin of safety−72.6%−27.6% (better)
Growth
Revenue growth (TTM)21.3% (better)8.1%
Revenue growth, 5Y average9.0% (better)−2.2%
Profitability
Gross margin61.3% (better)46.0%
Operating margin−2.6% (better)−4.7%
Net margin−2.3% (better)−40.7%
FCF margin0.79%5.4% (better)
Return on equity−1.9% (better)−42.1%
Return on invested capital−2.2% (better)−2.8%
Financial health
Debt / equity0.000.91 (better)
Interest coverage−25.0×–
Current ratio4.60 (better)1.15
Altman Z-score23.12 (better)3.46
Piotroski F-score66
Dividends and buybacks
Buyback yield–1.9%
Shareholder yield0.00%1.9% (better)
Ownership
Held by institutions93.2%107%
Held by insiders2.2%3.1%
Insider net buying, 12 months−$4.2M (better)−$8.7M
Short interest, % of float5.2%6.4%

Go deeper

Other comparisons

For information only, not investment advice. Check the source filings before relying on any figure.